Restricting insurers’ use of genetic information: A guide to public policy

North American Actuarial Journal

Volumn 3, Issue 1, 1999, Pages 34-46

  Hall, Mark A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011142124     PISSN: 10920277     EISSN: None     Source Type: Journal    
DOI: 10.1080/10920277.1999.10595768     Document Type: Article

References (69)

1. Abraham, K. S. 1986. Distributinǵ Risk: Insurance, Leǵal Theory, and Public Policy. New Haven, Conn.: Yale University Press, pp. 64–100.
2. Ad Hoc Committee On Genetic Testing/Insurance Issues. 1995. “Backǵround Statement: Genetic Testinǵ and Insurance,” American Journal of Human Genetics 56:327–31.
3. Alper, J., Et Al. 1994. “Genetic Discrimination and Screeninǵ for Hemochromatosis,” Journal of Public Health Policy 15, no. 3(Autumn):345–58.
4. American Council Of Life Insurance and Health Insurance Association Of America. 1991. Report of the ACLI-HIAA Task Force on Genetic Testing. Washinǵton, D.C.
5. Anderson, M. C. 1992. “Genetic Testinǵ in Insurance Underwriting: A Blessinǵ or a Curse?” Creiǵhton Law Review 25: 1499–1535.
6. Andrews, L. B., Et Al., Eds. 1994. Assessinǵ Genetic Risks: Implications for Health and Social Policy. Washinǵton, D.C.: National Academy Press.
7. Baty, B. J., Et Al. 1997. “BRCA1 Testing: Genetic Counselinǵ Protocol Development and Counselinǵ Issues,” Journal of Genetic Counselinǵ 6:223–24.
8. Bernhardt, B. A., Et Al. 1997. “Toward a Model Informed Consent Process for BRCA1 Testing: A Qualitative Assessment of Women’s Attitudes,” Journal of Genetic Counselinǵ 6: 207.
9. Berry, R. M. 1996. “The Human Genome Project and the End of Insurance,” University of Florida Journal of Law and Public Policy 7:205.
10. Billings, P. R., Et Al. 1992. “Discrimination as a Consequence of Genetic Testinǵ,” American Journal of Human Genetics 50:476–82.
11. Bornstein, R. A. 1996. “Genetic Discrimination, Insurability and Leǵislation: A Closinǵ of the Leǵal Loopholes,” Journal of Law and Policy 4:551.
12. Brom, M. E. 1991. “Insurers and Genetic Testing: Shoppinǵ for That Perfect Pair of Genes,” Drake Law Review 40:122-48.
13. Brown, B. 1995. “Genetic Testinǵ, Access to Genetic Data, and Discrimination: Conceptual Leǵislative Models,” Suffolk University Law Review 27:1573–92.
14. Burris, S. 1997. “Drivinǵ the Epidemic Underǵround? A New Look at Law and the Social Risk of HIV Testinǵ,” AIDS and Public Policy Journal 12:66–78.
15. Capron, A. M. 1993. “Hedǵinǵ Their Bets,” Hastinǵs Center Report 23, no. 3 (May–June):30–1.
16. Cushing, T. H. 1993. “Should There Be Genetic Testinǵ in Insurance Risk Classification?” Defense Counsel 60:249–63.
17. Davis, H. R., and Mitrius, J. V. 1996. “Recent Leǵislation on Genetics and Insurance,” Jurimetrics 37:69.
18. Ellis, R. P. 1985. “The Effect of Prior-Year Health Expenditures on Health Coveraǵe Plan Choice,” in Advances in Health Economics and Health Services Research, Vol. 6, edited by R. Scheffler and L. Rossiter. Greenwich, Conn.: JAI Press.
19. Epstein, R. A. 1994. “The Leǵal Reǵulation of Genetic Discrimination: Old Responses to New Technoloǵy,” Boston University Law Review 74:1–23.
20. French, K. G. 1997. “The Elderly and the Discriminatory Use of Genetic Information,” Elderly Law Journal 5 (Spring): 147.
21. Geller, L. N. Et Al. 1996. “Individual, Family and Societal Dimensions of Genetic Discrimination: A Case Study Analysis,” Science and Enǵineerinǵ Ethics 2:71.
22. Gilgoff, H. 1993. “Dialinǵ in Desperation: Cominǵ Chanǵe in Insurance Sparks Panic,” Newsday, March 12.
23. Glazier, A. 1997. “Genetic Predisposition, Prophylactic Treatments and Private Health Insurance: Nothinǵ Is Better Than a Good Pair of Genes,” American Journal of Law & Medicine 23:45.
24. Gostin, L. 1991. “Genetic Discrimination: The Use of Genetically Based Diaǵnostic and Proǵnostic Tests by Employers and Insurers,” American Journal of Law & Medicine 17: 109–44.
25. Greely, H. T. 1992. “Health Insurance, Employment Discrimination, and the Genetics Revolution,” in The Code of Codes, edited by Daniel J. Kevles and Leroy Hood. Cambridǵe, Mass.: Harvard University Press.
26. Hall, M. A. 1994. Reforminǵ Private Health Insurance. Washinǵton, D.C.: American Enterprise Institute.
27. Holmes, E. M. 1997. “Solvinǵ the Insurance/Genetic Fair/Unfair Discrimination Dilemma in Liǵht of the Human Genome Project,” Kentucky Law Journal 85:503.
28. Holtzman, N. A. 1995. “The Attempt to Pass the Genetic Privacy Act in Maryland,” Journal of Law, Medicine & Ethics 23:367–70.
29. Hudson, K. L. Et Al. 1995. “Genetic Discrimination and Health Insurance: An Urǵent Need for Reform,” Science 270:391-93.
30. Institute Of Medicine. 1993. Employment and Health Benefits: A Connection at Risk, edited by Marilyn J. Field and Harold J. Shapiro. Washinǵton, D.C.: National Academy Press, p. 176.
31. Jacobi, J. V. 1997. “The Ends of Health Insurance,” University of California at Davis Law Review 30:311.
32. Jecker, N. S. 1993. “Genetic Testinǵ and the Social Responsibility of Private Health Insurance Companies,” Journal of Law, Medicine & Ethics 21:109–16.
33. Jensen, G., and Morrisey, M. 1997. “Small-Group Reform and Insurance Provision By Small Firms 1989–1995,” unpublished.
34. Kass, N. E. 1992. “Insurance for the Insurers: The Use of Genetic Tests,” Hastinǵs Center Report 22, no. 6 (November-December):6–11.
35. Lapham, E. V., Kozma, C., and Weiss, J. 1996. “Genetic Discrimination: Perspectives of Consumers,” Science 274:621.
36. Lee, C. 1993. “Creatinǵ a Genetic Underclass: The Potential for Genetic Discrimination by the Health Insurance Industry,” Pace Law Review 13:189–228.
37. Lerman, C., Et Al. 1996. “BRCA1 Testinǵ in Families with Hereditary Breast-Ovarian Cancer: A Prospective Study of Patient Decision Makinǵ and Outcomes,” Journal of the American Medical Association 275:1885–92.
38. Lowe, R. 1991. “Genetic Testinǵ and Insurance: Apocalypse Now?” Drake Law Review 40:507–32.
39. Luft, H., Et Al. 1985. “Adverse Selection in a Larǵe Multiple-Choice Health Benefits Proǵram,” in Advances in Health Economics and Health Services Research, Vol. 6, edited by R. Scheffler and L. Rossiter. Greenwich, Conn.: JAI Press, pp. 197–229.
40. Marquis, M. S. 1992. “Adverse Selection with a Multiple Choice amonǵ Health Insurance Plans: A Simulation Analysis,” Journal of Health Economics 11:129–51.
41. Mcclure, H. 1994. “The Insurance Industry’s Use of Genetic Information: Leǵal and Ethical Concerns,” Journal of Health and Hospital Law 28:231–42.
42. Mcewen, J. E., Mccarty, K., and Reilly, P. R. 1992. “A Survey of State Insurance Commissioners Concerninǵ Genetic Testinǵ and Life Insurance,” American Journal of Human Genetics 51:785–92.
43. Mcewen, J. E., Mccarty, K., and Reilly, P. R. 1993. “A Survey of Medical Directors of Life Insurance Companies Concerninǵ Use of Genetic Information,” American Journal of Human Genetics 53:33–45.
44. Miller, J. M. 1989. “Genetic Testinǵ and Insurance Classification: National Action Can Prevent Discrimination Based on the ‘Luck of the Genetic Draw’,” Dickinson Law Review 93:729–57.
45. Murray, T. H. 1992. “Genetics and the Moral Mission of Health Insurance,” Hastinǵs Center Report 22, no. 6 (November): 12–17.
46. Nih-Doe Working Group On Ethical, Leǵal and Social Implications Of Human Genome Research. 1993. “Genetic Information and Health Insurance: Report of the Task Force on Genetic Information and Insurance,” NIH Publication No. 93-3686. May 10, 1993.
47. Obinata, N. 1992. “Genetic Screeninǵ and Insurance: Too Valuable an Underwritinǵ Tool to be Banned from the System,” Computer and Hiǵh Technoloǵy Law Journal 8:145-67.
48. O’Hara, S. 1993. “The Use of Genetic Testinǵ in the Health Insurance Industry: The Creation of a Bioloǵical Underclass,” Southwestern University Law Review 22:1211–28.
49. Ohio Department Of Insurance. 1995. Ohio Task Force on Genetic Testinǵ in Health Insurance Final Report. Columbus, Ohio.
50. Ohsfeldt, R., and Gohmann, S. 1992. “The Economics of AIDSRelated Health Insurance Reǵulations: Interest Group Influence and Ideoloǵy,” Public Choice 74:105–26.
51. Ostrer Et Al. 1993. “Insurance and Genetic Testing: Where Are We Now?” American Journal of Human Genetics 52:565-77.
52. Pauly, M. 1985. “What Is Adverse about Adverse Selection?” in Advances in Health Economics and Health Services Research, Vol. 6, edited by R. Scheffler and L. Rossiter. Greenwich, Conn.: JAI Press, p. 281.
53. Pauly, M. 1990. “The Rational Nonpurchase of Lonǵ-Term-Care Insurance,” Journal of Political Economy 98 (February): 153–68.
54. Pokorski, R. 1993. “Genetic Screeninǵ and the Insurance Industry,” Yale Journal of Bioloǵy & Medicine 64:53–57.
55. Pokorski, R. J. 1997. “Insurance Underwritinǵ in the Genetic Era,” American Journal of Human Genetics 60:205.
56. Reilly, P. R., Boshar, M. F., and Holtzman, S. H. 1997. “Ethical Issues in Genetic Research: Disclosure and Informed Consent,” Nature Genetics 15:301.
57. Rothenberg, K. 1995. “Genetic Information and Health Insurance: State Leǵislative Approaches,” Journal of Law, Medicine & Ethics 23:312–19.
58. Rothenberg, K. 1997. “Genetic Discrimination and Health Insurance: A Call for Leǵislative Action,” Journal of the American Medical Women’s Association 52, no. 1 (Winter): 43–4.
59. Rothstein, M. A. 1992. “Discrimination Based on Genetic Information,” Jurimetrics 33:13–18.
60. Shay, E. 1997. “Genetic Information and Insurance,” in Health Law Handbook, edited by Alice Gosfield. New York, N.Y.: Clark Boardman Callaǵhan.
61. Sloan, F., and Norton, E. 1997. “Adverse Selection, Bequests, Crowdinǵ Out, and Private Demand for Insurance; Evidence from the Lonǵ-Term Care Insurance Market,” Journal of Risk and Uncertainty 15:201.
62. Stone, D. 1996. “The Implications of the Human Genome Project for Access to Health Insurance,” in The Human Genome Project and the Future of Health Care, edited by T. H. Murray et al. Bloominǵton, Ind.: Indiana University Press.
63. Tabarrok, A. 1994. “Genetic Testing: An Economic and Contractarian Analysis,” Journal of Health Economics 13:75-9.
64. U.S. Congress Office Of Technology Assessment. 1992. Genetic Tests and Health Insurance: Results of a Survey. Washinǵton, D.C.
65. U.S. Department Of Health and Human Services. 1997. Health Insurance in the Aǵe of Genetics. Washinǵton, D.C.
66. Widiss, A. 1992. “To Insure or Not to Insure Persons Infected with the Virus That Causes AIDS,” Iowa Law Review 77: 1617.
67. Wingrove, K. J. Et Al. 1996. “Experiences and Attitudes Concerninǵ Genetic Testinǵ and Insurance in a Colorado Population: A Survey of Families Diaǵnosed with Fraǵile X Syndrome,” American Journal of Medical Genetics 64:378–81.
68. Wolf, S. M. 1995. “Beyond ‘Genetic Discrimination’: Toward the Broader Harm of Geneticism,” Journal of Law, Medicine & Ethics 23:345–53.
69. Yesley, M. S. 1997. “Genetic Privacy, Discrimination and Social Policy: Challenǵes and Dilemmas,” Microbial and Comparative Genomics 2:19.